• <table id="gigg0"></table>
  • west china medical publishers
    Author
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Author "HONGZhen" 2 results
    • Feasibility and acceptability of smart phone applications for seizure management in China: questionnaire study among patients with epilepsy and children and adolescents' caregivers

      ObjectiveTo determine the feasibility as well as the attitudes among caregivers of children and adolescents with epilepsy and adult patients with epilepsy in China towards the use of smart phone applications (apps) for the management of seizures. MethodsThe caregivers of children and adolescents with epilepsy, ages ranging from 0 to 17 years old and adult patients who were more than 18 years old, were enrolled in the study from the Epilepsy Prevention and Cure Center of West China Hospital within the time period from June to December 2015. A questionnaire gauging the attitudes towards using apps for seizure management was administered to the 502 epilepsy patients and 390 caregivers of children and adolescents with epilepsy. ResultsAmong adult patients, they were more likely to use an app in those who were young, lived in cities, had higher education, had a stable employment and had frequent seizures (P=0.002, P<0.001, P=0.001, P<0.001, P=0.01). Among caregivers of children and adolescents with epilepsy, participants were more likely to use an app in those who were male (P=0.03), had a higher education level, a higher annual household income as well as stable job (P<0.001, P<0.001, P=0.02). ConclusionThe results of this study imply a favorable attitude towards the use of apps for seizure management among adult patients and caregivers of children and adolescents with epilepsy. The use of such apps in China represents a promising strategy among caregivers for seizure management.

      Release date:2016-11-28 01:27 Export PDF Favorites Scan
    • 鈉離子通道阻滯劑藥物治療局灶性癲癇的中國專家應用共識

      為鈉離子通道阻滯劑(sodium channel blockers,SCBs)在局灶性癲癇發作治療中的應用提供建議。由24名中國專家組成德爾菲共識組,通過3輪改良德爾菲法投票建立共識。指導委員會制定了9項關于SCBs治療局灶性癲癇發作的聲明,專家小組對這些聲明進行評估和投票。專家小組就奧卡西平、拉莫三嗪、拉考沙胺、艾司利卡西平、托吡酯、唑尼沙胺和西諾氨酯治療局灶性癲癇發作的建議以及SCBs的治療調整等9項聲明達成共識。通過改良德爾菲法形成了SCBs在局灶性癲癇發作中應用的中國專家共識,提出的推薦意見有助于指導臨床實踐和未來的研究。

      Release date:2025-09-05 01:18 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南